132 related articles for article (PubMed ID: 14740238)
1. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.
Kuhn H; Seggewiss H; Gietzen FH; Boekstegers P; Neuhaus L; Seipel L
Z Kardiol; 2004 Jan; 93(1):23-31. PubMed ID: 14740238
[TBL] [Abstract][Full Text] [Related]
2. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.
Faber L; Seggewiss H; Gietzen FH; Kuhn H; Boekstegers P; Neuhaus L; Seipel L; Horstkotte D
Z Kardiol; 2005 Aug; 94(8):516-23. PubMed ID: 16049653
[TBL] [Abstract][Full Text] [Related]
3. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
[TBL] [Abstract][Full Text] [Related]
4. [Transcoronary ablation of septal hypertrophy (TASH): a 5-year experience].
Kuhn H
Z Kardiol; 2000 Jun; 89(6):559-64. PubMed ID: 10929441
[TBL] [Abstract][Full Text] [Related]
5. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
7. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
[TBL] [Abstract][Full Text] [Related]
8. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
[TBL] [Abstract][Full Text] [Related]
9. Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.
Sohns C; Sossalla S; Schmitto JD; Jacobshagen C; Raab BW; Obenauer S; Maier LS
Clin Res Cardiol; 2010 Jun; 99(6):359-68. PubMed ID: 20503122
[TBL] [Abstract][Full Text] [Related]
10. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
11. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
12. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
14. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
16. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.
Sathyamurthy I; Nayak R; Oomman A; Subramanyan K; Kalarical MS; Mao R; Ramachandran P
Indian Heart J; 2014; 66(1):57-63. PubMed ID: 24581097
[TBL] [Abstract][Full Text] [Related]
17. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.
Gietzen FH; Leuner CJ; Obergassel L; Strunk-Mueller C; Kuhn H
Heart; 2004 Jun; 90(6):638-44. PubMed ID: 15145866
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Tsuchikane E; Takeda Y; Kobayashi T; Yachiku K; Nasu K; Kobayashi Y; Matsumoto H; Awata N
Circ J; 2003 Sep; 67(9):763-7. PubMed ID: 12939552
[TBL] [Abstract][Full Text] [Related]
19. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002).
Fernandes VL; Nagueh SF; Wang W; Roberts R; Spencer WH
Clin Cardiol; 2005 Mar; 28(3):124-30. PubMed ID: 15813618
[TBL] [Abstract][Full Text] [Related]
20. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
